Stay updated on AZD4785 Phase I Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.

Latest updates to the AZD4785 Phase I Dose-Escalation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase I clinical study for AZD4785, which included information on patient enrollment criteria and study design. Additionally, the name 'Non-Small Cell Lung Cancer' has been added, along with a new identifier related to the study.SummaryDifference54%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to AZD4785 Phase I Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.